A person with hairloss since COVID-19 is considering treatments like finasteride and minoxidil but is hesitant due to potential side effects. Suggestions include visiting a dermatologist, using a ketoconazole shampoo, and considering that post-COVIDhairloss might be an autoimmune response.
A 34-year-old man experienced hairloss during the COVID-19 pandemic and successfully treated it using minoxidil, reducing shampoo use, and taking fenugreek. He saw significant improvement within a few months and no longer appears bald.
COVID and COVID vaccination can trigger hairloss, primarily telogen effluvium, due to stress and immune system activation. Proper diagnosis and addressing factors like nutrition and stress are crucial for recovery.
The conversation discusses the progress of Clascoterone (Breezula) for hairloss treatment, noting that COVID-19 delayed female trials by three months but Phase III trials for males are proceeding with a Special Protocol Assessment filed with the FDA. Users express hope for Breezula as an alternative to existing treatments like finasteride and minoxidil, despite concerns about its potential high cost.
Finasteride users may have an increased risk of depression, anxiety, and suicidal thoughts, though some attribute these issues to hairloss itself. The link between finasteride and mental health effects is debated, with varying user experiences.